Combretastatin A-4 (CA-4) received significant interest as a potential anticancer agent in recent years. Several CA-4 analogs were synthesized and investigated to enhance the activity or solve the in vivo decreased activity of CA-4. The present study aims to investigate the chemotherapeutic and the antiproliferative effects of the mono and the dual therapy of the newly synthesized CA-4 analogs OMA1520 and OMA1774 against hepatocellularcarcinoma (HCC) induced in male adult rats by N-methylnitrosourea (MNU). 50 male rats were divided into 5 groups of 10 animals in each group. Group I: normal healthy control; group II: MNU treated group, group III: MNU animals treated by OMA1520, group IV: MNU animals treated by OMA1774, and group V: MNU animals treated by both OMA1520 and OMA1774. The rats were assessed for liver cancer progression or inhibition by evaluating the histopathological, immunohistochemical, biochemical, and antioxidant enzyme status. The present work indicated that OMA1520 and OMA1774 possessed substantial chemotherapeutic efficiency against HCC. The histological and immunohistochemical examinations of liver tissues confirmed the biochemical sera data. Also, they diminished the cytotoxic effects of MNU and restored the normal histological hepatic architecture. Both analogs restored the normal levels of liver enzymes and functions and revealed potential antioxidant effects. OMA1520 and OMA1774 reduced the inflammatory and tumor markers' elevated expressions in serum. Substantial evidence in our results suggests that both CA-4 analogs could be possible alternative anticancer agents, and their co-administration provides a synergistic activity.

Appendicitis is a common medical condition that affects millions of people worldwide. It is characterized by inflammation of the appendix. The exact mechanisms that trigger the inflammatory response in appendicitis are not well understood, but it is known that inflammatory mediators play a crucial role in the development and progression of the disease. In this review, we provide a comprehensive overview of the current understanding of the role of inflammatory mediators in the pathogenesis of appendicitis. This review article examines the various types of inflammatory mediators involved, including cytokines, chemokines, and prostaglandins, and discusses their interactions with other cells and molecules in the inflammatory cascade. Our review highlights the complex interplay between inflammatory mediators in the development of appendicitis and their potential implications for diagnosis and treatment of the disease. We discuss the potential for targeted therapies aimed at reducing the production or activity of specific inflammatory mediators, as well as the potential for new diagnostic approaches based on the detection of specific mediators in the blood or other bodily fluids. At the end, the role of inflammatory mediators in appendicitis is an active area of research, and continued investigation is necessary to fully elucidate the mechanisms involved. However, the growing understanding of the complex interactions between these molecules offers new opportunities for the development of targeted therapies and diagnostic tools for this common and potentially serious condition

Background: Diabetes mellitus (DM) has become a disease prevalent worldwide. Honey, which comprises predominantly bioactive constituents, has anti-inflammatory, antioxidant, and immunomodulating properties. Aim: Recent developments and benefits of natural products in treating various diseases have caught the attention of researchers. This study aims to investigate the antidiabetic effect of bee honey extract on induced diabetic Swiss mice. Materials and Methods: Fifty Swiss male mice were randomly assigned to five groups of 10 mice each. Group I served as the negative control; in group II, the mice received 2 mg/kg/b.wt of honey extract only; and groups III, IV, and V received cyclosporine (CsA) (20 mg/kg/day, s.c.) daily for 10 days prior to receiving streptozotocin (STZ) inoculated at multiple low doses (MLDSTZ) (30 mg/kg/day, i.p.) for five consecutive days. Group IV was administered with insulin initiated at a dose of 0.5 U/kg/b.wt as a standard treatment (positive control). Group V was administered 2 mg/kg/b.wt of honey extract, while group III received no treatment. Results: The results showed a significant hypoglycemic effect, increased body weight, increased liver glycogen levels, and the amelioration of antioxidant activities in groups IV and V compared with the diabetic group III. Moreover, serum matrix metalloproteinase (MMP-9) concentrations were significantly reduced in the mice treated with the insulin and honey extract in groups IV and V and the tissue inhibitor metalloproteinase-1 (TIMP-1) levels were significantly higher than the serum levels in group III. Furthermore, the histopathological examination of groups IV and V revealed regenerative changes with the restoration of normal islet cell architecture, as compared to the diabetic mice in group III. Compared to group I, group II showed no changes and exhibited non-significant data. Conclusion: Honey extract plays an effective role in improving all biomarkers in treated group V. Furthermore, MMP-9 and TIMP-1 are considered prognostic markers in the progression, severity, diagnosis, and treatment of type 1 DM. This may play an important role for the treatment of individuals in the future.

Purpose: A wide range of cytokines has been demonstrated to be involved in the etiology of type 1 diabetes mellitus (T1DM). Gene polymorphisms may potentially contribute to a hereditary predisposition toward circulating cytokine levels as (high, intermediate, or low) since they can affect cytokine production or function. The aim of this study was to investigate the roles of cytokine levels and the association of single-nucleotide polymorphisms (SNPs) within cytokine genes with T1DM in Saudi children.Methods: Totals of 91 well-characterized T1DM patients and 91 T1DM-free control subjects were enrolled in this study.Results: The levels of 3 circulating cytokines (transforming growth factor [TGF]-β1, interleukin [IL]-10, and IL-6) and 6 SNPs in 3 cytokine genes (TGF-β1 [rs1800470 and rs1800471], IL-10 [rs1800896, rs1800871, and rs1800872], and IL-6 [rs1800795]) that contribute to genetic susceptibility were measured by enzyme-linked immunosorbent assay and polymerase chain reaction with sequence-specific primers. Our fn dings show that TGF-β1 serum levels were signifcantly lower in the children with T1DM than in the control participants. The TGF-β1 genotypes with a high-production phenotype were signifcantly less frequent and those with a lowproduction phenotype were signifcantly more frequent in the children with T1DM compared to the control participants. respectively. Furthermore, the IL-6 genotype frequency with low level of IL-6 production were signifcantly increased in the T1DM group compared to the control group. Moreover, our data demonstrated no appreciable diferences in circulating serum level or genotype and phenotype of IL- 10 between the patients and controls.Conclusion: This kind of measurement, which considers the prediction of T1DM, may be useful in assessing the severity of T1DM and susceptibility to T1DM among Saudi children.

Background. Total thyroidectomy (TT) and subtotal thyroidectomy (ST) are surgical options for treating benign thyroid conditions. This retrospective study aimed to compare the outcomes of TT and ST in patients with benign thyroid disorders. Patients and Methods. One hundred patients with benign thyroid disorders were included in this study; 50 underwent TT and another 50 underwent ST. Data were collected from medical records, including demographic characteristics, preoperative thyroid function tests, intraoperative findings, postoperative complications. Results. Patients who underwent TT had a mean age of 45.6 ± 8.2 years, while for those who underwent ST, it was 47.3 ± 7.5 years. There were no significant differences in demographic characteristics between the two groups. Intraoperatively, the TT group had longer operative times than the ST group (125 ± 15 and 110 ± 12 min, respectively; p < 0.05). Postoperative complications such as recurrent laryngeal nerve injury and hypoparathyroidism were higher in the TT group compared to the ST group (TT was 8 (16%), 3 (6%), and ST was 4 (8%)1 (2%) respectively, p < 0.05). Long-term follow-up revealed similar rates of disease recurrence and the need for reoperation between the two groups. Conclusion. TT and ST are effective surgical options for the management of benign thyroid disorders. However, TT is associated with longer operative times and a higher risk of postoperative complications, particularly hypoparathyroidism and recurrent laryngeal nerve injury, than ST. Therefore, the choice between TT and ST should be made based on individual patient factors, lower associated complications, and surgeon expertise.